Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.2.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2022
STOCK-BASED COMPENSATION  
Schedule of amounts charged to expense for stock-based compensation related to employee and director stock option grants

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2022

    

2021

    

2022

    

2021

Employee and director stock option grants:

 

  

 

  

 

  

 

  

Research and development

$

37,211

$

62,655

$

123,638

$

133,450

General and administrative

 

330,548

 

358,506

 

967,879

 

612,892

Total stock-based compensation

$

367,759

$

421,161

$

1,091,517

$

746,342

Schedule of stock options activity

Weighted

Number of

Average

Shares Issuable

Remaining

Upon Exercise

Weighted

Contracted

Aggregate

of Outstanding

Average

Term in

Intrinsic

    

Options

    

Exercise Price

    

Years

    

Value

Outstanding at December 31, 2021

 

423,820

$

22.70

$

Granted

 

277,850

$

5.47

Forfeited

(95,200)

$

12.78

Outstanding at March 31, 2022

606,470

$

16.37

9.03

$

Granted

62,400

$

4.69

Forfeited

 

(11,543)

$

9.09

 

 

  

Outstanding at June 30, 2022

657,327

$

15.39

8.84

$

Granted

Forfeited

 

(3,064)

$

36.04

 

 

  

Outstanding at September 30, 2022

 

654,263

$

15.29

8.63

$

Exercisable, September 30, 2022

 

202,398

$

28.00

7.73

$

Unvested, September 30, 2022

 

451,865

$

9.59

9.04

$